Dialysis or kidney care without dialysis

    Whether an older adult with kidney failure should start dialysis, or choose conservative kidney management: full care for symptoms and kidney health, without dialysis.

    Adults aged 65 or older whose kidneys are failing (stage 5 chronic kidney disease), often with other illnesses. No randomized trial has compared the two paths.

    SourcedModeledNo projected outcomes are generated on this page.

    Pending clinical review. Each statement is paraphrased from the named source, but no clinician has reviewed this page yet. Use it to prepare questions, not to choose a treatment.

    What this decision concerns

    People who chose dialysis were generally younger, with fewer other conditions, fewer functional limits and less frailty, than people who chose conservative care. That difference shapes every comparison below.

    SourcedSystematic review and meta-analysis · 2022

    Compared with dialysis, the effects of conservative kidney management on death, hospital stays and quality of life are uncertain. The evidence comes only from non-randomized studies.

    SourcedCochrane systematic review · 2025

    The options

    Start dialysis

    Treatment that filters the blood, usually several sessions a week, alongside other kidney care.

    • In 12 studies that adjusted for differences between groups, people who chose dialysis had a lower risk of death than people who chose conservative care (hazard ratio 0.47).

      Applies to: Cohort studies of adults with kidney failure who chose either path; 22 studies and 21,344 patients in the review.

      SourcedSystematic review and meta-analysis · 2022

    • In older or more seriously ill subgroups, the lower risk of death with dialysis remained statistically significant, though those analyses were not adjusted.

      Applies to: Subgroups by age or comorbidity within the same review.

      SourcedSystematic review and meta-analysis · 2022

    • Unplanned hospital admissions were twice as frequent in the dialysis group.

      Applies to: 510 adults aged 65 or older with stage 4 or 5 kidney disease at a unit with a kidney supportive care program; the conservative group was older (mean 84 vs 74).

      SourcedProspective kidney supportive care cohort · 2023

    • People on a dialysis pathway had 282.7 hospital-free days a year from the treatment decision, compared with 352.7 for people on conservative care.

      Applies to: 366 adults aged 70 or older with advanced kidney disease at one Dutch hospital, 240 on a dialysis pathway and 126 on conservative care.

      SourcedDutch hospital cohort study · 2018

    • Among people who died, 66% of those treated with dialysis or a transplant died in hospital, compared with 42% of those on conservative care.

      Applies to: 247 deaths among 721 patients from 66 Australian renal units. The comparison group includes people with a transplant as well as on dialysis.

      SourcedAustralian multicenter cohort study · 2016

    Choose conservative kidney management, without dialysis

    Ongoing care for symptoms, kidney function and comfort, with no dialysis. A person can revisit the choice.

    • People on conservative care had 352.7 hospital-free days a year from the treatment decision, compared with 282.7 on a dialysis pathway.

      Applies to: 366 adults aged 70 or older with advanced kidney disease at one Dutch hospital, 240 on a dialysis pathway and 126 on conservative care.

      SourcedDutch hospital cohort study · 2018

    • The survival benefit of the dialysis pathway shrank or was no longer significant in people aged 80 or older, or with severe other illness.

      Applies to: 366 adults aged 70 or older with advanced kidney disease at one Dutch hospital, 240 on a dialysis pathway and 126 on conservative care.

      SourcedDutch hospital cohort study · 2018

    • In a kidney supportive care program, 59% of people managed without dialysis reported better symptoms by their third clinic visit.

      Applies to: The 280 people managed without dialysis in the same cohort.

      SourcedProspective kidney supportive care cohort · 2023

    • Among people who died, 57% of those on conservative care received specialist palliative care, compared with 26% of those treated with dialysis or a transplant.

      Applies to: 247 deaths among 721 patients from 66 Australian renal units. The comparison group includes people with a transplant as well as on dialysis.

      SourcedAustralian multicenter cohort study · 2016

    • Median survival from the treatment decision was 14 months with conservative management and 53 months with dialysis. People in the conservative group were older and had more other illnesses.

      Applies to: 510 adults aged 65 or older with stage 4 or 5 kidney disease at a unit with a kidney supportive care program; the conservative group was older (mean 84 vs 74).

      SourcedProspective kidney supportive care cohort · 2023

    • Across studies, unadjusted median survival ranged from 6 to 31 months with conservative care and from 20 to 67 months with dialysis.

      Applies to: Cohort studies in the review; unadjusted, so differences between the groups are not removed.

      SourcedSystematic review and meta-analysis · 2022

    • Of 102 people who planned conservative care, 8% later switched to dialysis, mostly to manage symptoms.

      Applies to: Australian patients planning conservative care, median age 80.

      SourcedAustralian multicenter cohort study · 2016

    Set against what matters to you

    Modeled

    Read from what you saved on this device.

    What sources report about what matters to you

    Nothing yet. Mark what matters to you, and anything the sources say about it shows up here.

    Pulls in two directions

    Nothing so far pulls against anything else.

    Still unknown

    • Nothing is marked as a priority yet, so nothing here is connected to what matters to you. The options and their sources are still readable below.

      Not in the sources here.

    • The 2025 Cochrane review found no randomized trials: 24 non-randomized studies of 26,127 people. It rated the evidence very low certainty because of imbalances between groups.

      Cochrane systematic review, 2025 statement

    • High risk of bias and uneven reporting prevent firm conclusions, and the results cannot be applied to an individual person.

      Systematic review and meta-analysis, 2022 statement

    • Quality of life was compared in only two studies (186 people), with small, very uncertain differences.

      Cochrane systematic review, 2025 statement

    • What each path asks of family and caregivers is not measured in the sources recorded here.

      Not in the sources here.

    Worth asking

    • What would dialysis mean for me week to week: where, how often, and for how long each time?
    • For someone with my age and health, what do you expect with and without dialysis?
    • What does conservative kidney management include here, and who provides it?
    • If I choose one path, can I change my mind later, and how would we decide?
    • What matters most to me in the time ahead, and which path fits it?
    Start with what matters

    How this measures up

    Checked against IPDAS 5.0: 10 met, 1 partly met, 3 not met

    Sets source-backed statements about named options against what the person said matters. Does not meet the development and evaluation standard a patient decision aid requires. Three further stages would be needed to call it a patient decision aid: essential-criteria appraisal, an independent bias appraisal, and an evaluation of what it changes for the people who use it. None has been done. 4 criteria below are not fully met.

    Qualifying criteria

    • MetHealth conditionchecked automatically

      A source-backed description of the health condition or event is recorded separately from the option comparison.

    • MetExplicit decisionchecked automatically

      States the decision: "Whether an older adult with kidney failure should start dialysis, or choose conservative kidney management: full care for symptoms and kidney health, without dialysis."

    • MetTarget audiencechecked automatically

      Names who this is for: "Adults aged 65 or older whose kidneys are failing (stage 5 chronic kidney disease), often with other illnesses. No randomized trial has compared the two paths."

    • MetOptionschecked automatically

      2 options, including an explicit wait-or-decline option.

    • MetBenefitschecked automatically

      6 recorded statements read as supporting an option.

    • MetHarmschecked automatically

      6 recorded statements read as burdening an option.

    • Not metValues clarificationrecorded judgment

      Not assessed. An unassessed criterion is not a met one.

    Bias reduction

    • Partly metBest available evidencechecked automatically

      5 primary sources cited, each paraphrased closely. Dated currentness checks found no final newer edition of any source. That remains a negative currentness finding rather than proof that no update is underway.

    • Not metUser involvement in developmentrecorded judgment

      No patient, caregiver, or clinician took part in developing this journey. No usability or comprehension testing has been run on it.

    • MetNeutral presentation of optionschecked automatically

      Every option carries at least one statement in each direction, so no option is recorded as all upside or all downside.

    • MetComplete citationschecked automatically

      5 sources, each with a full citation, a resolving identifier, a publication date, and the date and route it was read.

    • MetPublication or version datechecked automatically

      Last reviewed 2026-11-14.

    • Not metUpdate policyrecorded judgment

      Each journey records when it was last reviewed. A recheck cadence and triggers are proposed, and source recheck due dates are computed from them, but no owner has adopted the policy. This stays unmet until one does.

    • MetFunding disclosedrecorded judgment

      Funding and editorial independence are stated at /independence.

    Screening decisions

    • Not applicableWhat the test measureschecked automatically

      This journey is not a screening decision.

    • Not applicableConsequences of a positive resultchecked automatically

      This journey is not a screening decision.

    • Not applicableNext steps after either resultchecked automatically

      This journey is not a screening decision.

    • Not applicableOverdiagnosis and false positiveschecked automatically

      This journey is not a screening decision.

    This checks the seven IPDAS 5.0 qualifying criteria, seven bias-reduction criteria, and four screening-specific criteria against what each journey holds. IPDAS 5.0 contains more than these. A criterion absent here has not been assessed and is not passed. Standard: IPDAS 5.0, published 2026-06-12. Assessment is by Values in Care, not by IPDAS or any outside reviewer.

    Sources

    Sourced
    • Yang JW, Natale P, Kim S, et al. Conservative kidney management versus dialysis for stage 5 chronic kidney disease in older people. Cochrane Database Syst Rev. 2025;12(12):CD015151.

      https://doi.org/10.1002/14651858.CD015151.pub2

      Read 2026-11-14 from the PubMed record (structured abstract of the version of record).

      Currentness check · 2026-11-14

      This December 2025 Cochrane review, searched to September 2025, is the newest synthesis of the comparison identified.

      Method: PubMed searches via the PubMed MCP connector for systematic reviews of dialysis versus conservative kidney management published from 2022.

      Not covered: Trial registries were not searched; the Prepare for Kidney Care randomized trial (ISRCTN17133653) had no indexed results.

      Adjacent evidence, not incorporated into this journey: Jongejan et al., Kidney Med 2026 (PMID 42529257), a single-center cohort, separates people choosing conservative care by dialysis suitability; a clinical reviewer should decide whether it belongs in this journey.

    • Voorend CGN, van Oevelen M, Verberne WR, et al. Survival of patients who opt for dialysis versus conservative care: a systematic review and meta-analysis. Nephrol Dial Transplant. 2022;37(8):1529-1544.

      https://doi.org/10.1093/ndt/gfac010

      Read 2026-11-14 from the PubMed record (structured abstract of the version of record).

      Currentness check · 2026-11-14

      The 2025 Cochrane review covers a broader question and is cited alongside this one; no later review of survival by chosen pathway was identified.

      Method: PubMed searches via the PubMed MCP connector for later reviews of survival with dialysis versus conservative care.

      Not covered: Only the first results of each search were reviewed.

    • Verberne WR, Dijkers J, Kelder JC, et al. Value-based evaluation of dialysis versus conservative care in older patients with advanced chronic kidney disease: a cohort study. BMC Nephrol. 2018;19(1):205.

      https://doi.org/10.1186/s12882-018-1004-4

      Read 2026-11-14 from the PubMed record (structured abstract of the version of record).

      Currentness check · 2026-11-14

      An observational cohort is not superseded by later studies; later work adds to it rather than replaces it.

      Method: PubMed record review via the PubMed MCP connector.

      Not covered: Corrections or later reanalyses of this cohort were not searched for separately.

    • Chou A, Li C, Farshid S, et al. Survival, symptoms and hospitalization of older patients with advanced chronic kidney disease managed without dialysis. Nephrol Dial Transplant. 2023;38(2):405-413.

      https://doi.org/10.1093/ndt/gfac154

      Read 2026-11-14 from the PubMed record (structured abstract of the version of record).

      Currentness check · 2026-11-14

      An observational cohort is not superseded by later studies; later work adds to it rather than replaces it.

      Method: PubMed record review via the PubMed MCP connector.

      Not covered: Corrections or later reanalyses of this cohort were not searched for separately.

    • Morton RL, Webster AC, McGeechan K, et al. Conservative management and end-of-life care in an Australian cohort with ESRD. Clin J Am Soc Nephrol. 2016;11(12):2195-2203.

      https://doi.org/10.2215/CJN.11861115

      Read 2026-11-14 from the PubMed record (structured abstract of the version of record).

      Currentness check · 2026-11-14

      An observational cohort is not superseded by later studies; later work adds to it rather than replaces it.

      Method: PubMed record review via the PubMed MCP connector.

      Not covered: Corrections or later reanalyses of this cohort were not searched for separately.

      Adjacent evidence, not incorporated into this journey: Walavalkar et al., Can J Kidney Health Dis 2022 (PMID 35450152), a systematic review, reports significant caregiver burden with conservative kidney management, similar to caring for someone on dialysis. A clinical reviewer should decide whether it belongs in this journey.

    Each clinical statement above paraphrases one of these sources closely. Filing it under a priority, or reading it against priorities you saved, is a Values in Care editorial operation rather than a source finding.

    Open Source Watch